key: cord-0700419-mi1cfh9d
authors: Lanier, Kasey; Kuruvilla, Merin; Shih, Jennifer
title: Patient satisfaction and utilization of telemedicine services in allergy: an institutional survey
date: 2020-10-08
journal: J Allergy Clin Immunol Pract
DOI: 10.1016/j.jaip.2020.09.047
sha: 7d6329f89adeca60bde9d1507a951a029da360c5
doc_id: 700419
cord_uid: mi1cfh9d

nan

We would like to acknowledge the contribution of Grace Kim with the Biostatistics, Epidemiology, & 23 Research Design (BERD) Research Forum for her assistance with the statistical analysis and the 24 construction of this manuscript. 25 26 Clinical Implications: 27

The adoption of telemedicine services by the allergist community was minimal prior to the SARS-CoV-2 28

pandemic, but has gained dramatic momentum in recent months. We present the results of a survey 29 study aimed to measure patient satisfaction with a cloud-based telemedicine platform performed at an 30 academic allergy clinic during the pandemic. 31 32 J o u r n a l P r e -p r o o f Despite the exponential growth of telemedicine in the past five years in the United States, its adoption 33 by the allergist community was minimal prior to the pandemic(1). The delay in uptake is notable since 34 this specialty is especially prime for telehealth services(2). Allergists treat a generally healthy patient 35 base and manage a range of diagnoses amenable to telemedicine modalities. However, allergists also 36 rely on several procedures for effective patient management. These can be challenging to conduct using 37 telehealth alone and may account for some of the inertia in adopting these services. 38

Direct to consumer telehealth, dominated by the for-profit private sector, was the most popular form of 39 telemedicine prior to the SARS-CoV2 pandemic(3). With the current pandemic and in the advent of 40

improved CMS and third-party reimbursement for telehealth, the expansion of direct to consumer 41 telehealth among allergists has gained abrupt and dramatic momentum. At the Emory Allergy Clinic, a 42

telemedicine program was rolled out in a highly expedited fashion within one week in order to maintain 43 access while limiting infectious risk. From a provider and administrative standpoint, we have continually 44 sought to fine-tune and readjust delivery of services. It is however imperative to evaluate telehealth 45 delivery models not only in terms of efficiency and efficacy but also to measure patient acceptance and 46 satisfaction. We performed a survey study aimed to measure patient satisfaction with a cloud-based 47 telemedicine platform. Patient data from our academic adult clinic was collected over the first two 48 months following its implementation (March 24 to May 29, 2020). We used a questionnaire-based 49 survey that was sent to all patients who utilized telemedicine services during this time. Qualifying visits 50

were defined as those involving synchronous two-way audiovisual encounters between the allergy 51 provider and the patient using Zoom and transcribed into PowerChart. 52

Patients were contacted to complete the survey by a member of the study team who was not present 53 during the telemedicine appointment in order to minimize bias. The questionnaire consisted of six 54 questions that prompted patients to grade their satisfaction with various aspects of their telemedicine 55 visit ( Figure 1 ). Their responses were scaled from 0 to 10, with 10 representing the highest satisfaction 56 score. The scale was dichotomized as a response of 10 versus less than 10, in accordance with other 57 measures of patient satisfaction(4). 58

A total of 297 patients were seen in 289 encounters during the two-month study period. 17 % of visits 59

were new consultations and 83% were established follow-ups. There was a 58% response rate. 78% of 60 respondents were female, and the mean age was 45 years. Patient demographics as well as insurance 61

information, are outlined in Table 1 . The primary diagnoses were asthma in 48 % patients, immune 62 deficiency in 20 %, rhinitis in 14 %, urticaria/angioedema in 9 %, food allergy in 6% and drug allergy in 63 3%. 64

Overall, 88 % of patients rated their comfort level seeing a doctor via telemedicine as a 10. 93% of 65 respondents stated that their doctor explained their condition in an easily understood manner. 79% 66 strongly agreed that connecting their telehealth appointments was easy. Only 46% indicated their 67 preference for future telemedicine visits following resolution of the pandemic, while 77% would strongly 68 recommend telemedicine services to others. 40% rated their virtual visit equivalent or superior to a 69 traditional outpatient encounter. Figure 1 illustrates responses to each question. There were a variety of 70 reasons stated by responders who would not preferentially elect for telehealth again. Some were 71 disappointed with the limitations of the physical exam and access to ancillary testing such as labs and 72 pulmonary function tests. Others expressed discomfort with video conferencing technology, while a 73 minority expressed a compromise to the level of rapport with the doctor. Those who highly prefer 74 telehealth visits expressed satisfaction with convenience, decreased wait times, and saving money and 75 transportation time. 76

Logistic regression analysis was performed to evaluate potential factors influencing patient satisfaction. 77

Notably, Caucasian patients were 18.5 times more likely to express comfort with telemedicine 78 encounters as compared with Hispanic patients. Patients with government insurance were 2.5 times 79 more likely to choose telemedicine even after the pandemic and 2.7 times more likely to recommend 80 telemedicine to others. We did not ascertain significant associations with satisfaction scores for gender 81 or underlying diagnosis. 82

Our data has implications for present and continuing service delivery. It remains to be seen whether 83 current practice will translate into a longer-term acceptance of telehealth in allergy following resolution 84 of the COVID19 pandemic. Telemedicine has shown in previous studies to increase access to care, 85

improve health outcomes and reduce costs, (5), but a Zoom platform has obvious limitations, and is 86 less suitable for visits requiring a physical examination or diagnostic evaluation. In a large cohort of 87 telehealth patients from a tertiary center, only 25% of new allergy consults and <10% of follow up 88 encounters requested in-person evaluations(6). In a pediatric study, asthma outcomes were comparable 89 in matched cohorts seen either via telemedicine or in person (7), and this study design would be helpful 90

for each allergy diagnosis in the future. 91

Our study has several shortcomings. The questionnaire was numerically scored and not open-ended, 92

and did not formally elicit patient-specific feedback. Additionally, our study only included adult patients 93 older than 18 years old and cannot be generalized to pediatric populations. Also, the study design self-94 selected patients with experience in video-conferencing, thus excluding those without access to this 95 technology who were unable to schedule a visit. In addition, our telehealth platform is non-facilitated 96 and few of our providers had previously utilized telehealth. Thus, our outcomes and experiences cannot 97 be extrapolated to other centers with different levels of resources and training. 98

In conclusion, it appears feasible for allergists to provide high-quality care via telemedicine based on 99 patient satisfaction, however there is a great deal of reluctance to preferentially elect telehealth over in-100 person visits. These findings are congruent with previous reports on patient experience with telehealth 101 that have been overall favorable (8, 9) . Future studies should focus on clinical outcomes stratified by 102 underlying diagnosis. We also recognize that our findings are applicable only to patients with the 103 technical proficiency to perform these visits, and the opinions of those without such experience must be 104 accounted for. 105 106 107 108 J o u r n a l P r e -p r o o f 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% I am likely to recommend telemedicine services to others. I think that seeing a doctor using telemedicine is just as good as seeing a doctor in person. 

Telemedicine in the Era of COVID-19

Direct-to-Consumer Telemedicine

Direct to Consumer Telemedicine

Development, implementation, 115 and public reporting of the HCAHPS survey

American College of Allergy

Immunology Position Paper on the Use of Telemedicine for Allergists

Outcomes From a Regional Synchronous Tele-Allergy Service

Telemedicine is as effective as in-person visits for 122 patients with asthma

Patient Uptake, Experience, and 124 Satisfaction Using Web-Based and Face-to-Face Hearing Health Services: Process Evaluation Study

Video Visits Using Veterans Affairs Telehealth Tablets: Survey Study

Figure 1 Legend: Survey Responses Scale1 (Strongly Disagree) to 10

J o u r n a l P r e -p r o o f